Saroja Pharma Ind Peer Comparison
NSE: SAROJA
₹36.00
₹0.00 (0.00%)As on 20-Nov-2026 13:01IST
Market cap
₹14 Cr
Revenue (TTM)
₹70 Cr
P/E Ratio
9
P/B Ratio
0.8
Div. Yield
0 %
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
14 | 670 | 448 | 231 | 148 |
Revenue (₹ Cr) |
70 | 26 | 668 | 615 | 101 |
Net Profit (₹ Cr) |
1.61 | 19.32 | 27.20 | 10.02 | 71.17 |
Net Margin (%) |
2.30 | 37.13 | 4.01 | 1.63 | 70.56 |
RoE (%) |
9.79 | 0.80 | 20.48 | 18.32 | 14.07 |
Price to Earnings |
8.97 | 34.66 | 16.46 | 22.78 | 2.09 |
Price-To-Book |
0.84 | 0.30 | 3.31 | 4.08 | 0.26 |
Income Statement (₹ Cr)
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
|
Operating Revenue
|
70.13 | 32.00 | 652.44 | 342.91 | 41.16 |
|
Total Income
|
70.24 | 57.23 | 663.63 | 343.38 | 41.28 |
|
Total Expenditure
|
66.41 | 35.72 | 641.25 | 330.78 | 17.17 |
|
EBITDA
|
3.72 | -3.72 | 11.19 | 12.13 | 23.99 |
|
Depreciation
|
0.11 | 0.68 | 0.12 | 2.87 | 0.50 |
|
EBIT
|
3.61 | -4.40 | 11.07 | 9.26 | 23.49 |
|
Interest
|
1.49 | -- | 0.08 | 1.68 | 1.14 |
|
Other Income
|
0.11 | 25.23 | 11.19 | 0.47 | 0.13 |
|
Exceptional Items
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
2.23 | 20.83 | 22.18 | 8.07 | 22.48 |
|
Provision for Tax
|
0.62 | 0.11 | 5.69 | 2.08 | 4.49 |
|
Profit after Tax
|
1.61 | 20.71 | 16.49 | 5.99 | 17.99 |
Liabilities (₹ Cr)
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
17.29 | 2,446.77 | 130.26 | 54.07 | 435.67 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
7.36 | 143.95 | 6.84 | 0.20 | 9.45 |
|
Current Liabilities
|
17.09 | 28.11 | 101.08 | 50.67 | 2.43 |
|
Total Liabilities
|
41.75 | 2,618.84 | 238.18 | 105.29 | 447.55 |
Assets (₹ Cr)
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
23.19 | 2,571.65 | 8.50 | 17.13 | 363.28 |
|
Current Assets
|
18.56 | 47.19 | 229.68 | 87.81 | 84.27 |
|
Total Assets
|
41.75 | 2,618.84 | 238.18 | 105.29 | 447.55 |
|
Total Debt*
|
14.41 | 0.00 | 0.49 | 41.69 | 0.12 |
|
Net Current Assets
|
1.47 | 19.08 | 128.60 | 37.13 | 81.83 |
|
Contingent Liabilities
|
-- | 23.78 | 6.45 | -- | 0.02 |
Cashflow (₹ Cr)
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
7.44 | -3.40 | -16.08 | -15.97 | -60.00 |
|
Cash Flow from Investing Activities
|
-11.68 | 9.89 | 21.23 | -0.68 | 76.22 |
|
Cash from Financing Activities
|
4.25 | -3.48 | -12.84 | 16.71 | -6.50 |
|
Net Cash Inflow / Outflow
|
0.01 | 3.02 | -7.68 | 0.06 | 9.72 |
Ratios
Profitability Ratios
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
|
ROCE (%)
|
13.10 | 0.85 | 17.26 | 11.68 | 5.01 |
|
ROE (%)
|
9.79 | 0.85 | 12.84 | 11.55 | 4.06 |
|
ROA (%)
|
3.97 | 0.76 | 6.52 | 6.72 | 3.71 |
|
EBIT Margin (%)
|
5.46 | 67.21 | 3.43 | 3.67 | 58.59 |
|
Net Margin (%)
|
2.30 | 36.19 | 2.49 | 1.75 | 43.58 |
|
Cash Profit Margin (%)
|
2.46 | 66.85 | 2.55 | 2.58 | 44.92 |
Growth Ratios
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
30.53 | -71.30 | 4.35 | 3.44 | 2.02 |
|
EBIT Growth (%)
|
28.90 | 835.73 | -26.72 | 19.63 | 9.33 |
|
Net Profit Growth (%)
|
56.10 | 7,341.93 | -26.15 | 64.12 | -4.74 |
|
EPS Growth (%)
|
56.10 | 7,345.00 | -26.15 | 64.11 | -4.74 |
|
Book Value Growth (%)
|
10.30 | -11.36 | 2.84 | 8.83 | -3.12 |
Valuation Ratios
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
|
Price / Earnings
|
6.97 | 30.94 | 18.19 | 121.95 | 4.86 |
|
Price / Book Value
|
0.65 | 0.28 | 2.30 | 13.52 | 0.20 |
|
Dividend Yield (%)
|
0.00 | 3.80 | 4.28 | 0.31 | 1.08 |
|
EV/EBITDA
|
6.61 | 29.06 | 12.99 | 61.31 | 3.18 |
|
Market Cap (₹ Cr)
|
11.26 | 640.87 | 300.06 | 730.95 | 87.41 |
Solvency Ratios
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.83 | 0.00 | 0.00 | 0.77 | 0.00 |
|
Short term debt to equity ratio
|
0.35 | -- | -- | 0.76 | -- |
|
Current Ratio
|
1.09 | 1.68 | 2.27 | 1.73 | 34.64 |
|
Quick Ratio
|
1.04 | 1.68 | 1.95 | 1.66 | 34.64 |
|
Interest Coverage
|
2.50 | -- | 275.88 | 5.82 | 20.69 |
Operating Efficiency Ratios
| Saroja Pharma Ind | Uniphos Ent | Vinyl Chemicals | A-1 Acid | Dhoot Ind Fin | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
24.67 | 81.70 | 18.92 | 22.75 | 6.29 |
|
Asset Turnover
|
1.73 | 0.01 | 2.58 | 3.85 | 0.08 |
|
Receivable days
|
114.19 | 298.19 | 63.83 | 68.47 | 30.21 |
|
Inventory Days
|
2.49 | 0.00 | 26.80 | 3.30 | 0.00 |
|
Payable days
|
64.92 | 159.17 | 65.05 | 5.35 | 77.74 |
|
Cash Conversion Cycle
|
51.77 | 139.01 | 25.59 | 66.42 | -47.52 |